Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4

Cancer Research

Volumn 60, Issue 2, 2000, Pages 276-281

  Talukder, Amjad H ^a   Vadlamudi, Ratna ^a   Mandal, Mahitosh ^a   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GAMMA UROGASTRONE; GENE PRODUCT; LEUCINE ZIPPER PROTEIN; NEU DIFFERENTIATION FACTOR; POLYPEPTIDE; SELECTIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; DNA BINDING; GENE EXPRESSION; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TRANSACTIVATION;

ACTIVATING TRANSCRIPTION FACTOR 4; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LEUCINE ZIPPERS; NEUREGULIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034650891     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 77-82, 1987.
2. Reese, D. M., and Slamon, D. J. HER-2/neu signal transaction in human breast and ovarian cancer. Stem Cells, 15: 1-8, 1997.
3. Hynes, N. C., and Stern, D. F. The biology of erbB2/neu/HER2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
4. Carraway, K., and Cantley, L. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994.
5. Pietras, R. J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L., Gorman, C. M., Parker, M. G., Sliwkowski, M. X., and Slamon, D. J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10: 2435-2446, 1995.
6. Kumar, R., Mandal, M., Ratzkin, B. J., Liu, N., and Lipton, A. NDF induces expression of a novel 46 kD protein in estrogen receptor positive breast cancer cells. J. Cell. Biochem., 62: 102-112, 1995.
7. Tang, C. K., Perez, C., Grunt, T., Waibel, C., Cho, C., and Lupu, R. Involvement of heregulin β2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res., 56: 3350-3358, 1996.
8. Adam, L., Vadiamudi, R., Kondapaka, S. B., Chemoff, J., Mendelsohn, J., and Kumar, R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem., 273: 28238-28246, 1998.
9. 38 mitogen-activated protein kinase. Oncogene, 18: 7253-7264, 1999.
10. Goodrich, J. A., Cutler, G., and Tjian, R. Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell, 84: 825-830, 1996.
11. Janknecht, R., and Hunter, T. Versatile molecular glue. Transcriptional control. Curr. Biol., 6: 951-954, 1996.
12. Vinson, C. R., Hai, T., and Boyd, S. M. Dimerization specificity of the leucine zipper containing BZIP motif on DNA binding: prediction and rational design. Genes Dev., 7: 1047-1058, 1993.
13. Verrijzer, C. P., and Tjian, R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci., 21: 338-342, 1996.
14. Lee, J-S., See, R. H., Deng, T., and Shl, Y. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol., 16: 4312-4326, 1996.
15. Vadlamudi, R., Adam, L., Tseng, B., Costa, L., and Kumar, R. Transcriptional regulation of paxillin expression by heregulin in human breast cancer cells. Cancer Res., 59: 2843-2846, 1999.
16. Kumar, R., and Atlas, . Interferon-α induces the expression of retinoblastoma gene product in Daudi cells. Proc. Natl. Acad. Sci. USA, 89: 6599-6503, 1991.
17. Vallejo, M., Ron, D., Miller, C. P., and Habener, J. F. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA, 90: 4679-4683, 1993.
18. Mandal, M., Maggirwar, S. B., Sharma, N., Kaufmann, S. H., Sun, S-C., and Kumar, R. Bcl-2 prevents CD-95 (Fas/APO-1)-induced degradation of lamin B and poly-(ADP-ribose) polymerase and restores the NF-κB signaling pathway. J. Biol. Chem., 271: 30354-30359, 1996.
19. Liang, G., and Hai, T. Characterization of human activating transcription factor 4, a transcriptional activator that interacts with multiple domains of cAMP responsive element-binding protein binding protein. J. Biol. Chem., 272: 24088-24095, 1997.
20. Whelan, J., Ghersa, P., van Huijsduijnen, R. H., Gray, J., Chandra, G., Talabot, F., and DeLamarter, J. F. An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res., 19: 2645-2653, 1991.
21. Lin, A., Minden, A., Martinetto, H., Claret, F-X., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science (Washington DC), 268: 286-290, 1995.
22. ATF4 promoter, Gene Bank accession number AC002036, submitted to GenBank by Evans, G. A., Athanasiou, M., Aguayo, P., Armstrong, D., Basit, M., Buettner, J., Bumeister, R., Card, P., deSailboat, F., Dunn, J., et al.
23. Zhang, G. J., and Adachi, I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastasis breast carcinoma: correlations with clinicopathological features and prognosis. Int. J. Cancer, 14: 71-77, 1999.